Company Filing History:
2 out of 1,743 
2 out of 11 
2 out of 6 
Years Active: 2024-2025
Title: Stanislas Mondot: Innovator in Pulmonary Health
Introduction
Stanislas Mondot is a notable inventor based in Jouy-en-Josas, France. He has made significant contributions to the field of pulmonary health through his innovative research and inventions. With a total of 2 patents, Mondot's work focuses on predicting the risk of developing pulmonary colonization and infection, particularly in patients suffering from cystic fibrosis.
Latest Patents
Mondot's latest patents involve methods for predicting the risk of developing pulmonary colonization and infection. The present invention relates to analyzing the respiratory tract microbiota from sputum samples of 65 patients. The inventors discovered that patients who remained uninfected exhibited a three-fold higher abundance of specific bacteria compared to other groups. In particular, the invention outlines a method for predicting the risk of developing pulmonary colonization and infection in subjects suffering from cystic fibrosis by measuring the abundance of certain genera of bacteria in biological samples obtained from these subjects.
Career Highlights
Throughout his career, Mondot has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the Regional University Hospital of Brest (Centre Hospitalier Régional Et Universitaire De Brest). His research has contributed to a better understanding of pulmonary health and the microbiota's role in respiratory infections.
Collaborations
Some of his notable coworkers include Geneviève Hery-Arnaud and Jérôme Mounier. Their collaborative efforts have further advanced the research in pulmonary health and infection prediction.
Conclusion
Stanislas Mondot's innovative work in predicting pulmonary infections has the potential to significantly impact the treatment and management of cystic fibrosis. His contributions to the field highlight the importance of microbiota analysis in understanding respiratory health.